Fusion Pharmaceuticals Inc.
FUSN · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $630,531 | $137,808 | $177,637 | $258,891 |
| - Cash | $61,925 | $43,861 | $52,898 | $90,517 |
| + Debt | $50,331 | $40,253 | $6,722 | $0 |
| Enterprise Value | $618,937 | $134,200 | $131,461 | $168,374 |
| Revenue | $2,068 | $1,461 | $1,440 | $0 |
| % Growth | 41.5% | 1.5% | – | – |
| Gross Profit | $723 | -$57,434 | -$54,917 | -$482 |
| % Margin | 35% | -3,931.1% | -3,813.7% | – |
| EBITDA | -$87,599 | -$87,262 | -$81,381 | -$31,054 |
| % Margin | -4,235.9% | -5,972.8% | -5,651.5% | – |
| Net Income | -$94,897 | -$87,612 | -$81,047 | -$78,333 |
| % Margin | -4,588.8% | -5,996.7% | -5,628.3% | – |
| EPS Diluted | -1.45 | -2 | -1.9 | -3.56 |
| % Growth | 27.5% | -5.3% | 46.6% | – |
| Operating Cash Flow | -$81,802 | -$73,276 | -$75,740 | -$29,767 |
| Capital Expenditures | -$3,890 | -$2,142 | -$1,491 | -$1,123 |
| Free Cash Flow | -$85,692 | -$75,418 | -$77,231 | -$30,890 |